Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG Fusion in Acute Peripheral Nerve Injuries
NCT04789044Phase 2Active, not recruiting
- Sponsor
- Major Extremity Trauma Research Consortium
- Start
- Jun 2023
- Primary completion
- Oct 2027
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of NTX-001 in peripheral nerve injury (PNI), sponsored by Major Extremity Trauma Research Consortium. Started Jun 2023; status: active, not recruiting.
02
Drugs
NTX-001
03
Conditions
peripheral nerve injury (PNI)
Beyond the preview
Go deeper on NCT04789044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04789044.